www.theguardian.com
4 months agoOMG science
Trial results for new lung cancer drug are off the charts', say doctors
A new drug, lorlatinib, has shown unprecedented success in stopping lung cancer progression, leading to a longer survival rate compared to standard treatment. [ more ]